Altimmune (ALT) Amortization of Goodwill (2017 - 2018)

Altimmune (ALT) reported Amortization of Goodwill of $490676.0 for Q1 2018, down 94.74% quarter-over-quarter from $9.3 million in Q4 2017.

Altimmune (ALT) Amortization of Goodwill (2017 - 2018) Analysis & Trends

Altimmune (ALT) has 2 years of Amortization of Goodwill data on file, last reported at $490676.0 in Q1 2018.

Amortization of Goodwill for Q1 2018 came in at $490676.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2018 was $9.8 million (changed N/A YoY), and the FY2017 annual result was $35.9 million, changed N/A from the prior year.
Amortization of Goodwill fell to $490676.0 in Q1 2018 per ALT's latest filing, from $9.3 million in the prior quarter.
Over five years, Amortization of Goodwill peaked at $26.6 million in Q3 2017 and troughed at $490676.0 in Q1 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Altimmune	336.67 Mn	336.67 Mn	-

Download Data